Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

Figure 2

Kaplan-Meier estimates of overall survival (A, C, E) and progression- free survival (B, D, F) for the 163 relapsed/primary refractory DLBCL patients stratified by the saaIPI as either low- (A, B), low-intermediate/high-intermediate (C, D) or high risk (E, F) were further stratified into low or high groups by the ALC/AMC ratio.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us